Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion can be supported by the determination of biomarkers. Biomarkers measure the biological changes that occur in the brains of … Read moreHow do Alzheimer’s biomarkers change over time?
Non-fibrillar amyloid-β (Aβ) plaques are considered to be a critical component of Alzheimer’s disease. Characterization of these species comes mainly from studies in cellular or animal models, but there is little data in intact human samples due to the lack of adequate optical microscopic resolution to study these small structures. Marta Querol-Vilaseca in collaboration with … Read moreSuper-resolution is here for amyloid plaques
On May 16th, the III Symposium of the DEGESCO Consortium on Dementia Genetics will be held in Málaga, in the context of the VI Málaga Alzheimer Conference, sponsored by CIBERNED and the Andalusian Institute of Neuroscience. During the DEGESCO symposium, the ongoing projects of the consortium will be brought together and new proposals will be … Read moreIII Symposium of the DEGESCO Consortium
Obesity and Alzheimer It has been established that middle-age obesity is a risk factor for Alzheimer’s disease, but the results from studies in older people are contradictory. Our recent study would explain the discrepancies on this topic. This work is the result of a collaborative effort between the Neuroimage team of the Sant Pau Memory … Read moreIs obesity a risk factor for Alzheimer’s disease?
The Instituto de Salud Carlos III (Institute of Health Carlos III) has awarded subvention grants to four research projects submitted by the Sant Pau Memory Unit in the 2018 call for Health Research and Development Strategy in the modality of Proyectos de Investigación en Salud (Health Research Projects). This is an annual national competitive call that … Read moreThe Instituto de Salud Carlos III awards subvention grants to four projects of the Sant Pau Memory Unit
Dr. María Carmona-Iragui has recently received the Doctoral Thesis Extraordinary Award in Neuroscience for her work entitled: “Sporadic cerebral amyloid angiopathy: beyond lobar intracerebral hemorrhage. Multimodal biomarker studies of atypical presentations”. Her work was co-directed by Dr. Rafael Blesa, Dr. Alberto Lleó and Dr. Juan Fortea, and deepened in the analysis of different forms of presentation … Read moreMaría Carmona-Iragui receives the Doctoral Extraordinary Award